Everpar Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-478
Closed -$233K 280
2025
Q2
$233K Sell
478
-7
-1% -$3.99K 0.11% 243
2025
Q1
$298K Buy
485
+40
+9% +$22.7K 0.16% 183
2024
Q4
$236K Sell
445
-97
-18% -$54.7K 0.12% 235
2024
Q3
$326K Sell
542
-38
-7% -$21.5K 0.17% 179
2024
Q2
$315K Buy
580
+27
+5% +$15.5K 0.16% 183
2024
Q1
$355K Sell
553
-394
-42% -$239K 0.22% 159
2023
Q4
$554K Buy
+947
New +$530K 0.26% 139

Other funds holding CHE

Everpar Advisors's CHE Position: Q3 2025 in Review

Everpar Advisors sold out of Chemed (CHE) in Q3 2025, closing a stake of 478 shares — an estimated $233K sold.

Everpar Advisors first reported a position in CHE in Q4 2023 and held it in 7 quarters. The position peaked at $554K in Q4 2023. 523 funds tracked by Wall St. Rank hold CHE as of Q3 2025.

  • Everpar Advisors reported no remaining Chemed position as of Q3 2025 after selling out during the quarter.
  • Everpar Advisors sold 478 Chemed shares in Q3 2025, an estimated $233K.
  • Everpar Advisors first reported a position in Chemed in Q4 2023 and held it in 7 quarters.
  • Everpar Advisors's Chemed position peaked at $554K in Q4 2023.
  • 523 funds tracked by Wall St. Rank held Chemed as of Q3 2025.

Based on Everpar Advisors's 13F filing for Q3 2025, filed 17 Oct 2025.